Serologicals Corporation President & CEO David A. Dodd to Speak at J. Mack Robinson College of Business at Georgia State Univers

Serologicals Corporation (NASDAQ: SERO) announced today
that Serologicals President and CEO David A. Dodd will be the featured
speaker on November 16, 2005 at the J. Mack Robinson College of
Business at Georgia State University. He will be taking part in the
Atlanta Business Leaders Speaker Series from 4:30 - 7:00 p.m. at the
GSU Student Center Auditorium in Downtown Atlanta on the GSU campus.
   Dodd's presentation, titled "Creating a Sustainable Business,"
will focus on strategies for how to grow and sustain a business. He
will use examples from the ongoing transformation of Serologicals
Corporation into a global leader in providing research & bioprocessing
products, technologies and services.
   During 2005, Dodd has been chosen as a "CEO Visionary" by Start
Magazine, as well as receiving the 2005 Oglethorpe Award from the
Atlanta Chapter of the British American Business Group, in recognition
of his ongoing leadership in fostering business relationships between
the U.S. and the United Kingdom.
   Serologicals Corporation (NASDAQ: SERO), headquartered in Atlanta,
GA., is a global leader in developing and commercializing consumable
biological products, enabling technologies and services in support of
biological research, drug discovery, and the bioprocessing of
life-enhancing products. Our customers include researchers at major
life science companies and leading research institutions involved in
key disciplines, such as neurology, oncology, hematology, immunology,
cardiology, proteomics, infectious diseases, cell signaling and stem
cell research. In addition, Serologicals is the world's leading
provider of monoclonal antibodies for the blood typing industry.
   Serologicals employs a total of more than 1,000 people worldwide
in three Serologicals' companies: Chemicon International,
headquartered in Temecula, CA, Upstate Group, LLC, headquartered in
Charlottesville, VA. and Celliance Corporation, headquartered in
Atlanta, GA.
   For more information, please visit our website:
www.serologicals.com.